Mostrar o rexistro simple do ítem
Effectiveness of rotavirus vaccination in Spain
dc.contributor.author | Martiñón-Torres, Federico | |
dc.contributor.author | Bouzón Alejandro, Marta | |
dc.contributor.author | Redondo Collazo, Lorenzo | |
dc.contributor.author | Sánchez-Lastres, Juan Manuel | |
dc.contributor.author | Pértega-Díaz, Sonia | |
dc.contributor.author | Seoane-Pillado, Teresa | |
dc.contributor.author | Mantiñón Sánchez, José María | |
dc.date.accessioned | 2022-06-20T08:42:04Z | |
dc.date.available | 2022-06-20T08:42:04Z | |
dc.date.issued | 2011-07-01 | |
dc.identifier.citation | Martinón-Torres F, Bouzón Alejandro M, Redondo Collazo L, Sánchez Lastres JM, Pértega Díaz S, Seoane Pillado MT, Martinón Sánchez JM; ROTACOST research team. Effectiveness of rotavirus vaccination in Spain. Hum Vaccin. 2011 Jul;7(7):757-61. doi: 10.4161/hv.7.7.15576. Epub 2011 Jul 1. PMID: 21521947. | es_ES |
dc.identifier.issn | 1554-8600 | |
dc.identifier.uri | http://hdl.handle.net/2183/30959 | |
dc.description.abstract | [Abstract] With the aim of determining rotavirus vaccine effectiveness (RVVE) in Spain, from Oct-2008/Jun-2009, 467 consecutive children below 2 years old with acute gastroenteritis (AGE) were recruited using a pediatric research network (ReGALIP-www.regalip.org) that includes primary, emergency and hospital care settings. Of 467 enrolled children, 32.3% were rotavirus positive and 35.0% had received at least one dose of any rotavirus vaccine. RRVE to prevent any episode of rotavirus AGE was 91.5% (95% CI: 83.7%-95.6%). RVVE to prevent hospitalization by rotavirus AGE was 95.6% (85.6-98.6%). No differences in RVVE were found regarding the vaccine used. Rotavirus vaccines have showed an outstanding effectiveness in Spain. | es_ES |
dc.description.sponsorship | Xunta de Galicia; 10PXIB918184PR | es_ES |
dc.description.sponsorship | Instituto de Salud Carlos III; RHI07/2 | es_ES |
dc.description.sponsorship | Instituto de Salud Carlos III; PS09749 | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Taylor & Francis | es_ES |
dc.relation.uri | https://doi.org/10.4161/hv.7.7.15576 | es_ES |
dc.subject | Rotavirus | es_ES |
dc.subject | Diarrhea | es_ES |
dc.subject | Rotavirus vaccine | es_ES |
dc.subject | Effectiveness | es_ES |
dc.subject | Infant | es_ES |
dc.title | Effectiveness of rotavirus vaccination in Spain | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.access | info:eu-repo/semantics/openAccess | es_ES |
UDC.journalTitle | Human Vaccines | es_ES |
UDC.volume | 7 | es_ES |
UDC.issue | 7 | es_ES |
UDC.startPage | 757 | es_ES |
UDC.endPage | 761 | es_ES |
Ficheiros no ítem
Este ítem aparece na(s) seguinte(s) colección(s)
-
INIBIC-ECB - Artigos [50]